Researchers Sequence the Ubiquitous Pseudomonas aeruginosa

Data derived from the Science Watch/Hot Papers database and the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. Pseudomonas aeruginosa gets around. The bacterium thrives in soil and marshes, on marine coasts, and in plant and animal tissues. Of particular interest is its occasional, but often devastating, inhabitation of the human environment. It is an important cause of bacteremia associated with bur

Written byJim Kling
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Pseudomonas aeruginosa gets around. The bacterium thrives in soil and marshes, on marine coasts, and in plant and animal tissues. Of particular interest is its occasional, but often devastating, inhabitation of the human environment. It is an important cause of bacteremia associated with burn wounds and with hospital-acquired pneumonia in patients on respirators. It is the microbe that most commonly infects the lungs of patients with cystic fibrosis.

Aside from its adaptability, P. aeruginosa is also famous for its natural drug resistance. In general, relatively high doses of aminoglycosides, such as tobramycin, extended-spectrum beta-lactams, and ciprofloxacin, are required to eradicate this organism. P. aeruginosa's genome is one of the largest and most complicated bacterial genomes known, with an estimated 6.3 million base pairs and 5,570 open reading frames, giving this prokaryote a complexity on par with simple eukaryotes.

AN UNUSUAL COLLABORATION P. aeruginosa's pathogenicity has made it a marked microbe, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies